Research groups
Milad Nazarzadeh
AS BSc MSc DPhil
Postdoctoral Research Fellow in Cardiovascular and Genetic Epidemiology
Genetic Epidemiology, Cardiovascular Diseases, Valvular Heart Diseases
Milad is a Postdoctoral Research Fellow in Cardiovascular and Genetic Epidemiology and British Heart Foundation postdoctoral fellow at the University of Oxford.
His research is focused on the use of multidisciplinary approaches that combine conventional and innovative research methodologies to provide strong evidence for cardiovascular risk factors and potential preventative measures, with a particular emphasis on genetic data analysis, electronic health records data and artificial intelligence.
Milad obtained his DPhil from the University of Oxford and was awarded an Immediate Postdoctoral Research Fellowship from the British Heart Foundation. Currently, his research project is centred around valvular heart diseases, which are relatively less studied conditions in the field of cardiovascular medicine. Milad's research explores different aspects of these diseases from various angles, with the aim of improving our understanding of these conditions and identifying potential new treatment strategies.
Milad's research interests include blood pressure, cardiovascular disease, and genetic epidemiology, integrating techniques such as individual-patient meta-analysis, clinical trials, Mendelian Randomisation, and artificial intelligence.
Recent publications
-
Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.
Journal article
Rao S. et al, (2022), Hypertension
-
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842
-
Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.
Journal article
Nazarzadeh M. et al, (2022), Cardiovasc Res
-
Correction: Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.
Journal article
Canoy D. et al, (2022), Osteoporos Int
-
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol
-
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
Journal article
Canoy D. et al, (2022), Current Cardiology Reports, 24, 851 - 860
-
Investigating the association of environmental exposures and all-cause mortality in the UK Biobank using sparse principal component analysis.
Journal article
Mamouei M. et al, (2022), Sci Rep, 12
-
ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study
Journal article
Mousavi SF. et al, (2022), Seizure, 97, 58 - 62
-
The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reports.
Journal article
Nazarzadeh M. et al, (2022), J Hypertens
-
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
Journal article
Canoy D. et al, (2022), Heart
